Management of sexual dysfunction due to central nervous system disorders: A systematic review

BJU International

Volumn 115, Issue S6, 2015, Pages 47-56

  Lombardi, Giuseppe ^a   Musco, Stefania ^a   Kessler, Thomas M ^b   Marzi, Vincenzo Li ^a   Lanciotti, Michele ^a   Del Popolo, Giulio ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Neurogenic erectile dysfunction; Neurogenic sexual dysfunction; Phosphodiesterase type 5 inhibitors

Indexed keywords

ANASTROZOLE; APOMORPHINE; CARBAMAZEPINE; FAMPRIDINE; LAMOTRIGINE; PERGOLIDE; PHENYTOIN; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; PROSTAGLANDIN E1; SEX HORMONE; SILDENAFIL; TADALAFIL; TESTOSTERONE; VALPROIC ACID; VARDENAFIL; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

CENTRAL NERVOUS SYSTEM DISEASE; DRUG WITHDRAWAL; ERECTILE DYSFUNCTION; FEMALE SEXUAL DYSFUNCTION; HEADACHE; HORMONE BLOOD LEVEL; HOT FLUSH; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; INTERNATIONAL INDEX OF ERECTILE FUNCTION 15; LABORATORY TEST; LOWER URINARY TRACT SYMPTOM; MALE SEXUAL DYSFUNCTION; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; PENIS PROSTHESIS; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SACRAL NERVE STIMULATION; SEXUAL DYSFUNCTION; SPINAL CORD INJURY; SYSTEMATIC REVIEW (TOPIC); UNSPECIFIED SIDE EFFECT; CLINICAL TRIAL (TOPIC); COMPLICATION; ELECTROSTIMULATION THERAPY; FEMALE; MALE; PROCEDURES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

CENTRAL NERVOUS SYSTEM DISEASES; CLINICAL TRIALS AS TOPIC; ELECTRIC STIMULATION THERAPY; ERECTILE DYSFUNCTION; FEMALE; HUMANS; MALE; NEUROLOGIC EXAMINATION; NEUROTRANSMITTER AGENTS; PENILE PROSTHESIS; PHOSPHODIESTERASE 5 INHIBITORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 84930391161     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.13055     Document Type: Review

References (64)

1. Rees PM, Fowler CJ, Maas CP. Sexual function in men and women with neurological disorders. Lancet 2007;369:512-25
2. Blok B, Pannek J, Castro-Diaz D et al. Guidelines on Neuro-Urology European Association of Urology Guidelines, 2015 edition. Available at: http://uroweb.org/guideline/neuro-urology. Accessed February 2015
3. Sipski ML, Arenas A. Female sexual function after spinal cord injury. Prog Brain Res 2006;152:441-7
4. Harden CL. Sexual dysfunction in women with epilepsy. Seizure 2008;17:131-5
5. Hess MJ, Hough S. Impact of spinal cord injury on sexuality: broad-based clinical practice intervention and practical application. J Spinal Cord Med 2012;35:211-8
6. Courtois F, Rodrigue X, Côté I et al. Sexual function and autonomic dysreflexia in men with spinal cord injuries: how should we treat? Spinal Cord 2012;50:869-77
7. Landtblom AM. Treatment of erectile dysfunction in multiple sclerosis. Expert Rev Neurother 2006;6:931-5
8. Guo ZN, He SY, Zhang HL, Wu J, Yang Y. Multiple sclerosis and sexual dysfunction. Asian J Androl 2012;14:530-5
9. Kessler TM, Fowler CJ, Panicker JN. Sexual dysfunction in multiple sclerosis. Expert Rev Neurother 2009;9:341-50
10. Bronner G, Elran E, Golomb J, Korczyn AD. Female sexuality in multiple sclerosis: the multidimensional nature of the problem and the intervention. Acta Neurol Scand 2010;121:289-301
11. Sakakibara R, Kishi M, Ogawa E et al. Bladder, bowel, and sexual dysfunction in Parkinson's disease. Parkinsons Dis 2011;2011:924605, 1-21
12. Lew-Starowicz M, Rola R. Sexual dysfunctions and sexual quality of life in men with multiple sclerosis. J SexMed 2014;11:1294-301
13. Forsythe E, Horsewell JE. Sexual rehabilitation of women with a spinal cord injury. Spinal Cord 2006;44:234-41
14. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-analyses: the PRISMA statement. Phys Ther 2009;89:873-80
15. Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version v. 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
16. Lombardi G, Macchiarella A, Cecconi F, Del Popolo G. Ten-year follow-up of sildenafil use in spinal cord-injured patients with erectile dysfunction. J SexMed 2009;6:3449-57
17. Del Popolo G, Li Marzi V, Mondaini N, Lombardi G. Time/duration effectiveness of sildenafil versus tadalafil in the treatment of erectile dysfunction in male spinal cord-injured patients. Spinal Cord 2004;42:643-8
18. Ergin S, Gunduz B, Ugurlu H et al. A placebo-controlled, multicenter, randomized, double-blind, flexible-dose, two-way crossover study to evaluate the efficacy and safety of sildenafil in men with traumatic spinal cord injury and erectile dysfunction. J Spinal Cord Med 2008;31:522-31
19. Khorrami MH, Javid A, Moshtaghi D, Nourimahdavi K, Mortazavi A, Zia HR. Sildenafil efficacy in erectile dysfunction secondary to spinal cord injury depends on the level of cord injuries. Int J Androl 2010;33:861-4
20. Safarinejad MR. Evaluation of the safety and efficacy of sildenafil citrate for erectile dysfunction in men with multiple sclerosis: a double-blind, placebo controlled, randomized study. J Urol 2009;181:252-8
21. Lombardi G, Macchiarella A, Del Popolo G. Efficacy and safety of tadalafil for erectile dysfunction in patients with multiple sclerosis. J SexMed 2010;7:2192-200
22. Lombardi G, Macchiarella A, Cecconi F, Del Popolo G. Efficacy and safety of medium and long-term tadalafil use in spinal cord patients with erectile dysfunction. J SexMed 2009;6:535-43
23. Kimoto Y, Sakamoto S, Fujikawa K, Tachibana T, Yamamoto N, Otani T. Up-titration of vardenafil dose from 10 mg to20 mg improved erectile function in men with spinal cord injury. Int J Urol 2006;13:1428-33
24. Safarinejad MR, Taghva A, Shekarchi B, Safarinejad S. Safety and efficacy of sildenafil citrate in the treatment of Parkinson-emergent erectile dysfunction: a double-blind, placebo-controlled, randomized study. Int J Impot Res 2010;22:325-35
25. Giuliano F, Sanchez-Ramos A, Löchner-Ernst D et al. Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury. Arch Neurol 2007;64:1584-92
26. Moemen MN, Fahmy I, Abdelaal M, Kamel I, Mansour M, Arafa MM. Erectile dysfunction in spinal cord-injured men: different treatment options. Int J Impot Res 2008;20:181-7
27. Fowler CJ, Miller JR, Sharief MK, Hussain IF, Stecher VJ. Sweeney A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis. J Neurol Neurosurg Psychiatry 2005;76:700-5
28. Giuliano F, Rubio-Aurioles E, Kennelly M et al. Vardenafil Study Group. Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury. Neurology 2006;66:210-6
29. Giuliano F, Rubio-Aurioles E, Kennelly M et al. Vardenafil Study Group. Vardenafil improves ejaculation success rates and self-confidence in men with erectile dysfunction due to spinal cord injury. Spine 2008;33:709-15
30. Morgentaler A, Barada J, Niederberger C et al. Efficacy and safety of tadalafil across ethnic groups and various risk factors in men with erectile dysfunction: use of a novel non inferiority study design. J SexMed 2006;3:492-503
31. Soler JM, Previnaire JG, Denys P, Chartier-Kastler E. Phosphodiesterase inhibitors in the treatment of erectile dysfunction in spinal cord-injured men. Spinal Cord 2007;45:169-73
32. Cardenas DD, Ditunno JF, Graziani V et al. Two phase 3, multicenter, randomized, placebo-controlled clinical trials off fampridine-SR for treatment of spasticity in chronic spinal cord injury. Spinal Cord 2014;52:70-6
33. Strebel RT, Reitz A, Tenti G, Curt A, Hauri D, Schurch B. Apomorphine sublingual as primary or secondary treatment for erectile dysfunction in patients with spinal cord injury. BJU Int 2004;93:100-4
34. Pohanka M, Kanovský P, Bares M, Pulkrábek J, Rektor I. The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: evidence from the results of an open, prospective, one-year trial. Parkinsonism Relat Disord 2005;11:509-12
35. Herzog AG, Farina EL, Drislane FW et al. A comparison of anastrozole and testosterone versus placebo and testosterone for treatment of sexual dysfunction in men with epilepsy and hypogonadism. Epilepsy Behav 2010;17:264-71
36. Shafik A, Shafik AA, Shafik IA, El Sibai O. Percutaneous perineal electrostimulation induces erection: clinical significance in patients with spinal cord injury and erectile dysfunction. J Spinal Cord Med 2008;31:40-3
37. Lombardi G, Mondaini N, Giubilei G, Macchiarella A, Lecconi F, Del Popolo G. Sacral neuromodulation for lower urinary tract dysfunction and impact on erectile function. J SexMed 2008;5:2135-40
38. Lombardi G, Nelli F, Mencarini M, Del Popolo G. Clinical concomitant benefits on pelvic floor dysfunctions after sacral neuromodulation in patients with incomplete spinal cord injury. Spinal Cord 2011;49:629-36
39. Sievert KD, Amend B, Gakis G et al. Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury. Ann Neurol 2010;67:74-84
40. Zermann DH, Kutzenberger J, Sauerwein D, Schubert J, Loeffler U. Penile prosthetic surgery in neurologically impaired patients: long-term followup. J Urol 2006;175:1041-4
41. Alexander MS, Rosen RC, Steinberg S, Symonds T, Haughie S, Hultling C. Sildenafil in women with sexual arousal disorder following spinal cord injury. Spinal Cord 2011;49:273-9
42. Dasgupta R, Wiseman OJ, Kanabar G, Fowler CJ, Mikol D. Efficacy of sildenafil in the treatment of female sexual dysfunction due to multiple sclerosis. J Urol 2004;171:1189-93
43. Lombardi G, Mondaini N, Macchiarella A, Cilotti A, Del Popolo G. Clinical female sexual outcome after sacral neuromodulation implant for lower urinary tract symptom (LUTS). J SexMed 2008;5:1411-7
44. Gil-Nagel A, López-Muñoz F, Serratosa JM, Moncada I, García-García P, Alamo C. Effect of lamotrigine on sexual function in patients with epilepsy. Seizure 2006;15:142-9
45. Sipski ML, Alexander CJ, Gomez-Marin O, Grossbard M, Rosen R. Effects of vibratory stimulation on sexual response in women with spinal cord injury. J Rehabil Res Dev 2005;42:609-16
46. Lombardi G, Del Popolo G, Macchiarella A, Mencarini M, Celso M. Sexual rehabilitation in women with spinal cord injury: a critical review of the literature. Spinal Cord 2010;48:842-9
47. Bong GW, Rovner ES. Sexual health in adult men with spina bifida. ScientificWorldJournal 2007;7:1466-9
48. Verhoef M, Barf HA, Vroege JA et al. Sex education, relationships, and sexuality in young adults with spina bifida. Arch Phys Med Rehabil 2005;86:979-87
49. Alexander MS, Alexander CJ. Recommendations for discussing sexuality after spinal cord injury/dysfunction in children, adolescents, and adults. J Spinal Cord Med 2007;30(Suppl. 1):S65-70
50. Basson R, Leiblum S, Brotto L et al. Revised definitions of women's sexual dysfunction. J SexMed 2004;1:40-80
51. Alsemari A. Hypogonadism and neurological diseases. Neurol Sci 2013;34:629-38
52. Lombardi G, Mondaini N, Macchiarella A, Del Popolo G. Female sexual dysfunction and hormonal status in spinal cord injured (SCI) patients. J Androl 2007;28:722-6
53. Lombardi G, Celso M, Bartelli M, Cilotti A, Del Popolo G. Female sexual dysfunction and hormonal status in multiple sclerosis patients. J SexMed 2011;8:1138-46
54. Maïmoun L, Fattal C, Micallef JP, Peruchon E, Rabischong P. Bone loss in spinal cord-injured patients: from physiopathology to therapy. Spinal Cord 2006;44:203-10
55. Hussain IF, Brady CM, Swinn MJ, Mathias CJ, Fowler CJ. Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry 2001;71:371-4
56. Lombardi G, Nelli F, Celso M, Mencarini M, Del Popolo G. Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature. J SexMed 2012;9:970-85
57. Gilad R, Lampl Y, Eshel Y, Sadeh M. Tonic-clonic seizures in patients taking sildenafil. BMJ 2002;325:869
58. Rättyä J, Turkka J, Pakarinen AJ et al. Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy. Neurology 2001;56:31-6
59. Morrell MJ, Flynn KL, Doñe S, Flaster E, Kalayjian L, Pack AM. Sexual dysfunction, sex steroid hormone abnormalities, and depression in women with epilepsy treated with antiepileptic drugs. Epilepsy Behav 2005;6:360-5
60. Stephen LJ, Kwan P, Shapiro D, Dominiczak M, Brodie MJ. Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy. Epilepsia 2001;42:1002-6
61. Pavlovich CP, Levinson AW, Su LM et al. Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomised double-blind trial with placebo. BJU Int 2013;112:844-51
62. Jadav AM, Wadhawan H, Jones GL, Wheldon LW, Radley SC, Brown SR. Does sacral nerve stimulation improve global pelvic function in women? Colorectal Dis 2013;15:848-57
63. Signorello D, Seitz CC, Berner L et al. Impact of sacral neuromodulation on female sexual function and his correlation with clinical outcome and quality of life indexes: a monocentric experience. J SexMed 2011;8:1147-55
64. Gacci M, Del Popolo G, Macchiarella A et al. Vardenafil improves urodynamic parameters in men with spinal cord injury: results from a single dose, pilot study. J Urol 2007;178:2040-3